Ventripoint Diagnostics Competitors and Similar CompaniesClear all

Ventripoint Diagnostics's competitors and similar companies include Alifax, BioFire Diagnostics, Nova Biomedical and HemoCue.

	Ventripoint Diagnostics Ventripoint Diagnostics is a medical device company engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease.	Alifax Alifax is a company providing solutions in clinical diagnostics.	BioFire Diagnostics BioFire Diagnostics is a company that provides molecular diagnostics solutions.	Nova Biomedical Nova Biomedical is a company that develops, manufactures, and sells advanced technology blood testing analyzers.	HemoCue HemoCue is a company providing medical diagnostic products for point-of-care testing.
Founding Date	Founding Date 2005	Founding Date 1988	Founding Date 1990	Founding Date 1976	Founding Date 1982
Type	Type Public	Type Private	Type Subsidiary	Type Private	Type Subsidiary
Tags	Tags Healthcare 3d modeling medical devices medical diagnostics medtech	Tags Healthcare medical devices medical diagnostics medtech	Tags Healthcare medical devices medical diagnostics medtech	Tags Healthcare medical devices medical diagnostics medtech	Tags Healthcare medical devices medical diagnostics medtech
Locations	Locations Toronto, CA HQ	Locations HQ	Locations Salt Lake City, US HQ	Locations Waltham, US HQ Jardim Canada, BR Mississauga, CA Les Ulis, FR Mörfelden Walldorf, DE Lainate, IT Tokyo, JP see more	Locations Ängelholm, SE HQ København, DK Meaux, FR Mumbai, IN New Delhi, IN Roma, IT Zoetermeer, NL see more
Employees	Employees N/A	Employees 2262% increase	Employees 6551% decrease	Employees 1,2771% increase	Employees 3674% decrease
Financial
Revenue (est.)	Revenue (est.) $95k (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr631m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods kr200.5m (FY, 2021)
Gross profit	Gross profit $95k (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit kr430.6m (FY, 2021)
Net income	Net income ($4.9m) (FY, 2024)	Net income N/A	Net income N/A	Net income N/A	Net income kr3.7m (FY, 2021)
Operating ⚠
Products	Products N/A	Products N/A	Products 4 (Apr, 2023)	Products 31 (Aug, 2023)	Products N/A
Trademark Applications (US)	Trademark Applications (US) N/A	Trademark Applications (US) N/A	Trademark Applications (US) N/A	Trademark Applications (US) 1 (Aug, 2023)	Trademark Applications (US) 1 (Apr, 2022)
Trademarks (US)	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) 16 (Aug, 2023)	Trademarks (US) 1 (Apr, 2022)
Funding
Total funding raised	Total funding raised $ 5.5m	Total funding raised N/A	Total funding raised $ 70m	Total funding raised N/A	Total funding raised N/A